This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Photon-counting CT (PCCT) technology has the potential to revolutionize cardiac imaging, according to a presentation delivered July 20 at the Society for Cardiovascular Computed Tomography (SCCT) annual meeting in Washington, DC. "The main use of coronary CT will be in preventive cardiology -- in addition to acting as a gatekeeper to interventional cardiology," said presenter U.
Large language models may pass medical exams with flying colors but using them for diagnoses would currently be grossly negligent. Medical chatbots make hasty diagnoses, do not adhere to guidelines, and would put patients' lives at risk. A team has systematically investigated whether this form of artificial intelligence (AI) would be suitable for everyday clinical practice.
Editor's note: As part of the celebration of AuntMinnie.com's upcoming 25th anniversary, we're presenting 25 for 25 -- a series featuring our most popular content for each of the last 25 years. New articles will be published each Monday until our official anniversary at RSNA 2024. In 2005, our top article reported on the fierce turf war in the U.S. between radiologists and cardiologists.
mtaschetta-millane Mon, 07/22/2024 - 08:56 July 22, 2024 — RefleXion Medical , an external-beam theranostic oncology company, today announced that researchers from multiple clinical programs will present pioneering scientific evidence in 37 oral and poster presentations confirming the efficacy and feasibility of the RefleXion X1 machine with SCINTIX® biology-guided radiotherapy (BgRT) at the 2024 American Association of Physicists in Medicine ( AAPM ) Annual Meeting in Los Angeles, July 21-25.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Qure.ai has received a Class III medical device license from Health Canada for all its medical imaging AI products. The license allows the company to expand its presence into the Canadian healthcare market, according to the vendor. The Class III license covers all of Qure.ai's flagship software, including qXR for chest x-ray images, cER for triaging neurocritical CT images, and qCT for lung nodule management on chest CT images.
A first-of-its-kind plaque analysis tool to be fully integrated with FFRCT provides impactful insights that enhance clinical decision-making and enable.
Adding dynamic CT perfusion (DynCTP) to cardiac CT angiography (CCTA) shortens time to diagnosis of coronary artery disease (CAD), according to research presented at the Society of Cardiovascular Computed Tomography (SCCT) meeting in Washington, DC. A team led by David Vilades Medel, PhD, of Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, found that the combination cut time to diagnosis by 42% and decreased the need for further functional tests by 48%.
New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Varian, a Siemens Healthineers company, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for new functionality on its Ethos therapy system. The latest iteration of Ethos features a streamlined workflow for daily treatment adaptation across more areas of the body and provides greater connectivity to patient data, according to the vendor.
“UCSF takes MRI Safety very seriously. It is a priority,” says MRI Safety Officer and MRI Supervisor Christina L. Calvin. This MRI Safety Week, July 21-27, Calvin spotlights the three most important things patients need to know.
AI firm Lunit is implementing its AI-powered breast cancer detection software, Lunit Insight MMG, in Qatar's national breast cancer screening program. Qatar's Primary Health Care Corporation (PHCC) has integrated Lunit Insight MMG into its "Screen for Life" program, the country's national breast and bowel cancer screening initiative. The deployment aims to improve early detection of breast cancer, potentially reducing missed diagnoses and improving survival rates in Qatar's triennial screening p
In comparison to systematic biopsy, researchers found that mpMRI-targeted biopsy had a nine percent higher detection rate for cribriform and intraductal prostate cancer subtypes that are associated with adverse outcomes.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Kelly Huang, PhD Business Wire Cardiovascular imaging AI firm Elucid has named Kelly Huang, PhD, as the company's president and CEO. Huang joins Elucid after serving as chief operating officer (COO) for Cardea Bio, a mass producer of biocompatible semiconductors that was acquired by Paragraf in 2023. Prior to that, he held the positions of COO and head of Nutra-Theraputic at L-Nutra.
While a variety of factors can influence key decisions such as career moves, conservative projections of absolutes can help reduce the risk of unwelcome surprises.
Dubai-based Zscale Labs is launching Neuromorphic AI, an AI software application for multilabel classification of chest radiographs. Neuromorphic AI leverages the firm's hyperdimensional computing and deep-learning technologies to assist radiologists and healthcare providers in diagnosing multiple chest conditions from x-ray images. Key features include an advanced spatial transformer network designed to improve the precision of image analysis and hyperdimensional computing encoding for pattern
This month’s Global Talent Update reports on the rise in the average starting pay for British jobs; efforts by the government to ensure that Malaysians have healthy working conditions; the pause in a controversial annual levy for expats in Nigeria; and the move to replace the peso with the American dollar as the currency of Argentina. EUROPE Average starting pay for British jobs rose in May at the fastest pace in four months despite a 20% annual fall in the number of jobs on offer, figures
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
In the fast-paced world of stroke care, the successful implementation of AI can make a profound difference in patient outcomes. Aidoc’s Stroke Care Coordination (CareCo) App has demonstrated remarkable success in several partner facilities, revolutionizing stroke care delivery. By closely examining these successful implementations, three key characteristics emerge as critical to their success: highly engaged project champions, the establishment of clear success metrics and thorough live training
Sandow et al (1) have performed a confirmatory follow-up study to the LEGACY trial (2), with the important additions of voxel-based posttreatment dosimetry and statistical analysis of dosimetric factors associated with complete response (CR). The authors reported a median radiation dose to the perfused nontumor target liver volume of 472 Gy compared with that of 410 Gy in the LEGACY study (2).
It’s normal to be concerned about radiation exposure because, in large doses, it can damage healthy living tissues and increase the risk of cancer. However, the doses used in medical imaging procedures such as X-rays and CT scans are low, and the benefits of the lives we save using these methods in emergencies and early detection of cancer and disease far outweigh the risks involved.
Desmoid fibromatosis (DF) was historically treated with wide resection. Cryoablation has emerged as a local treatment option with promising results; injury to surrounding structures, however, is a substantial concern (1). This case describes the use of artificial pneumoperitoneum to separate the abdominal wall and protect the small intestine from freezing damage during ablation.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content